Savara (SVRA) Other Non-Current Assets (2010 - 2026)
Savara (SVRA) reported Other Non-Current Assets of $11.4 million for Q1 2026, up 5.88% year-over-year from $10.7 million in Q1 2025, and down 2.34% on a QoQ basis from $11.6 million in Q4 2025.
Savara (SVRA) has 17 years of Other Non-Current Assets data on file, last reported at $11.4 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 5.88% year-over-year to $11.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.4 million (up 5.88% YoY) and the FY2025 annual result came in at $11.6 million, up 12.97% from the prior year.
- Other Non-Current Assets retreated to $11.4 million in Q1 2026 per SVRA's latest filing, from $11.6 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $11.6 million in Q4 2025 and bottomed at $116000.0 in Q4 2022.
- The 5-year median for Other Non-Current Assets is $10.3 million (2024), against an average of $6.7 million.
- The widest annual swing landed in 2022, when Other Non-Current Assets plunged 98.97%; it then surged 9348.28% in 2023.
- Tracing SVRA's Other Non-Current Assets over 5 years: stood at $116000.0 in 2022, then surged by 9348.28% to $11.0 million in 2023, then declined by 6.02% to $10.3 million in 2024, then advanced by 12.97% to $11.6 million in 2025, then decreased by 2.34% to $11.4 million in 2026.
- Per Business Quant, the three latest SVRA Other Non-Current Assets figures stand at $11.4 million (Q1 2026), $11.6 million (Q4 2025), and $990000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | 11.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.36 Mn |
| Dec 31, 2025 | 11.64 Mn |
| Sep 30, 2025 | 990,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 10.73 Mn |
| Dec 31, 2024 | 10.30 Mn |
| Sep 30, 2024 | 11.11 Mn |
| Jun 30, 2024 | 10.63 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 10.96 Mn |
| Sep 30, 2023 | 10.50 Mn |
| Jun 30, 2023 | 888,000.00 |
| Mar 31, 2023 | 868,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 9.75 Mn |
| Jun 30, 2022 | 952,000.00 |
| Mar 31, 2022 | 11.06 Mn |
| Dec 31, 2021 | 11.27 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 11.83 Mn |
| Mar 31, 2021 | 1.03 Mn |
| Dec 31, 2020 | 250,000.00 |
| Sep 30, 2020 | 11.64 Mn |
| Jun 30, 2020 | 11.16 Mn |
| Mar 31, 2020 | 1.31 Mn |
| Dec 31, 2019 | 11.11 Mn |
| Sep 30, 2019 | 1.65 Mn |
| Jun 30, 2019 | 221,000.00 |
| Mar 31, 2019 | 2.29 Mn |
| Dec 31, 2018 | 131,000.00 |
| Sep 30, 2018 | 54,000.00 |
| Jun 30, 2018 | 11.61 Mn |
| Mar 31, 2018 | 1.06 Mn |
| Dec 31, 2017 | 33.63 Mn |
| Sep 30, 2017 | 91,000.00 |
| Jun 30, 2017 | 99,000.00 |
| Mar 31, 2017 | 131,000.00 |
| Dec 31, 2016 | 10.48 Mn |
| Sep 30, 2016 | 6.50 Mn |
| Jun 30, 2016 | 131,000.00 |
| Mar 31, 2016 | 141,000.00 |
| Dec 31, 2015 | 8.55 Mn |
| Sep 30, 2015 | 8.55 Mn |
| Jun 30, 2015 | 8.55 Mn |
| Mar 31, 2015 | 8.55 Mn |
| Dec 31, 2014 | 8.55 Mn |
| Sep 30, 2014 | 363,497.00 |
| Jun 30, 2014 | 63,497.00 |
| Mar 31, 2014 | 83,542.00 |
| Dec 31, 2013 | 60,000.00 |
| Sep 30, 2013 | 6.55 Mn |
| Jun 30, 2013 | 6.55 Mn |
| Mar 31, 2013 | 6.55 Mn |
| Dec 31, 2012 | 6.55 Mn |
| Sep 30, 2012 | 43,912.00 |
| Jun 30, 2012 | 6.55 Mn |
| Mar 31, 2012 | 43,912.00 |
| Dec 31, 2011 | 6.55 Mn |
| Sep 30, 2011 | 48,311.00 |
| Jun 30, 2011 | 6.55 Mn |
| Dec 31, 2010 | 33,484.00 |